×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ANIP – ani pharmaceuticals, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ANIP
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
1/14
09:41 pm
anip
ANI Pharmaceuticals (ANIP) Is Up 7.0% After Raising 2026 Revenue Outlook and Expanding Rare Disease Team [Yahoo! Finance]
Low
Report
ANI Pharmaceuticals (ANIP) Is Up 7.0% After Raising 2026 Revenue Outlook and Expanding Rare Disease Team [Yahoo! Finance]
1/13
12:27 pm
anip
ANI Pharmaceuticals (ANIP) Stock Trades Down, Here Is Why [Yahoo! Finance]
Low
Report
ANI Pharmaceuticals (ANIP) Stock Trades Down, Here Is Why [Yahoo! Finance]
1/13
12:07 pm
anip
ANI Pharmaceuticals: Strong 2025 Finish And Bullish 2026 Guidance [Seeking Alpha]
Low
Report
ANI Pharmaceuticals: Strong 2025 Finish And Bullish 2026 Guidance [Seeking Alpha]
1/13
09:54 am
anip
Stocks making big moves yesterday: OneMain, Nextpower, ANI Pharmaceuticals, Akamai Technologies, and Lemonade [Yahoo! Finance]
Low
Report
Stocks making big moves yesterday: OneMain, Nextpower, ANI Pharmaceuticals, Akamai Technologies, and Lemonade [Yahoo! Finance]
1/12
05:53 pm
anip
Why ANI Pharmaceuticals (ANIP) Stock Is Trading Up Today [Yahoo! Finance]
Medium
Report
Why ANI Pharmaceuticals (ANIP) Stock Is Trading Up Today [Yahoo! Finance]
1/12
07:05 am
anip
ANI Pharmaceuticals Highlights Significant Growth in 2025, Provides 2026 Financial Guidance, and Outlines Strategic Priorities [Yahoo! Finance]
Medium
Report
ANI Pharmaceuticals Highlights Significant Growth in 2025, Provides 2026 Financial Guidance, and Outlines Strategic Priorities [Yahoo! Finance]
1/12
06:50 am
anip
ANI Pharmaceuticals Highlights Significant Growth in 2025, Provides 2026 Financial Guidance, and Outlines Strategic Priorities
High
Report
ANI Pharmaceuticals Highlights Significant Growth in 2025, Provides 2026 Financial Guidance, and Outlines Strategic Priorities
1/8
06:52 am
anip
1 of Wall Street's Favorite Stock for Long-Term Investors and 2 That Underwhelm [Yahoo! Finance]
Low
Report
1 of Wall Street's Favorite Stock for Long-Term Investors and 2 That Underwhelm [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
11/7/2025
06:50 am
ANIP
ani pharmaceuticals, inc.
BEAT
Report
-1.7%
ani pharmaceuticals, inc.
5/9/2025
06:50 am
ANIP
ani pharmaceuticals, inc.
BEAT
Report
-10.5%
ani pharmaceuticals, inc.
2/28/2025
06:50 am
ANIP
ani pharmaceuticals, inc.
BEAT
Report
11.4%
ani pharmaceuticals, inc.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
1/14
06:14 pm
anip
Form 4 ANI PHARMACEUTICALS INC For: Jan 13 Filed by: Cook Meredith
Low
Report
Form 4 ANI PHARMACEUTICALS INC For: Jan 13 Filed by: Cook Meredith
1/12
04:16 pm
anip
Form 8-K ANI PHARMACEUTICALS INC For: Jan 12
Low
Report
Form 8-K ANI PHARMACEUTICALS INC For: Jan 12
12/19
04:47 pm
anip
Form 4 ANI PHARMACEUTICALS INC For: Dec 18 Filed by: Davis Krista
Medium
Report
Form 4 ANI PHARMACEUTICALS INC For: Dec 18 Filed by: Davis Krista
12/12
04:26 pm
anip
Form 4 ANI PHARMACEUTICALS INC For: Dec 12 Filed by: Cook Meredith
Low
Report
Form 4 ANI PHARMACEUTICALS INC For: Dec 12 Filed by: Cook Meredith
12/9
06:10 pm
anip
Form 4 ANI PHARMACEUTICALS INC For: Dec 05 Filed by: TANNENBAUM RENEE P
Low
Report
Form 4 ANI PHARMACEUTICALS INC For: Dec 05 Filed by: TANNENBAUM RENEE P
12/9
05:12 pm
anip
Form 144 ANI PHARMACEUTICALS INC Filed by: TANNENBAUM RENEE P
Low
Report
Form 144 ANI PHARMACEUTICALS INC Filed by: TANNENBAUM RENEE P
12/1
06:59 am
anip
Form 8-K ANI PHARMACEUTICALS INC For: Nov 24
Low
Report
Form 8-K ANI PHARMACEUTICALS INC For: Nov 24
11/17
06:01 pm
anip
Form 4 ANI PHARMACEUTICALS INC For: Nov 13 Filed by: Walsh Patrick D
Low
Report
Form 4 ANI PHARMACEUTICALS INC For: Nov 13 Filed by: Walsh Patrick D
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/24
ANI Pharmaceuticals Announces the Filing of a Prior Approval Supplement for Purified Cortrophin® Gel 80 U/mL
18.7%
6/18 ANI Pharmaceuticals Expands Generic Pipeline with Acquisition of Seven Development Stage Drug Products from Coeptis Pharmaceuticals, Inc. 10.0%
4/8 Form 4 ANI PHARMACEUTICALS INC For: Apr 06 Filed by: Schrepfer Robert W 8.0%
4/13 ANI Announces FDA Acceptance of Supplemental Filing for Cortrophin® Gel 80 U/mL 6.1%
9/12 ANI Pharmaceuticals Inc (NASDAQ: ANIP) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. 5.6%
9/12 ANI Pharmaceuticals Inc (NASDAQ: ANIP) is now covered by analysts at Guggenheim. They set a "buy" rating on the stock. 4.1%
1/9 ANI Pharmaceuticals Announces Acquisition of Commercial and Pipeline Generic Products from Amerigen Pharmaceuticals, Ltd. 3.5%
6/28 ANI Pharmaceuticals Inc (NASDAQ: ANIP) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. 3.4%
5/9 Q1/2019 3/31/2019 EPS 1.300 ZacksConsensus 1.030 ActVsEst 0.270 - Beat 3.1%
10/22 ANI Pharmaceuticals Inc (NASDAQ: ANIP) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. 3.0%
6/18 ANI Pharmaceuticals Expands Generic Pipeline with Acquisition of Seven Development Stage Drug Products from Coeptis Pharmaceuticals, Inc. 10.0%
4/8 Form 4 ANI PHARMACEUTICALS INC For: Apr 06 Filed by: Schrepfer Robert W 8.0%
4/13 ANI Announces FDA Acceptance of Supplemental Filing for Cortrophin® Gel 80 U/mL 6.1%
9/12 ANI Pharmaceuticals Inc (NASDAQ: ANIP) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. 5.6%
9/12 ANI Pharmaceuticals Inc (NASDAQ: ANIP) is now covered by analysts at Guggenheim. They set a "buy" rating on the stock. 4.1%
1/9 ANI Pharmaceuticals Announces Acquisition of Commercial and Pipeline Generic Products from Amerigen Pharmaceuticals, Ltd. 3.5%
6/28 ANI Pharmaceuticals Inc (NASDAQ: ANIP) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. 3.4%
5/9 Q1/2019 3/31/2019 EPS 1.300 ZacksConsensus 1.030 ActVsEst 0.270 - Beat 3.1%
10/22 ANI Pharmaceuticals Inc (NASDAQ: ANIP) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. 3.0%
TOP News Decliners
11/6
Q3/2019 9/30/2019 EPS 1.230 ZacksConsensus 1.320 ActVsEst (0.090) - Miss
-23.7%
2/27 Q4/2019 12/31/2019 EPS 1.080 ZacksConsensus 1.020 ActVsEst 0.060 - Beat -18.7%
8/7 Q2/2019 6/30/2019 EPS 1.440 ZacksConsensus 1.180 ActVsEst 0.260 - Beat -15.1%
4/14 ANI Announces Upcoming Departure of CEO -9.0%
3/2 ANI Pharmaceuticals Announces FDA Approval of Memantine Hydrochloride Extended-Release Capsules -7.8%
3/4 ANI Pharmaceuticals Inc (NASDAQ: ANIP) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. -7.3%
3/7 ANI Pharmaceuticals Inc (NASDAQ: ANIP) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. -6.4%
3/31 Form 4 ANI PHARMACEUTICALS INC For: Mar 28 Filed by: PRZYBYL ARTHUR -6.3%
4/14 ANI Pharmaceuticals Inc (NASDAQ: ANIP) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. -6.0%
1/7 ANI Pharmaceuticals Inc (NASDAQ: ANIP) was downgraded by analysts at BidaskClub from a "strong-buy" rating to a "buy" rating. -5.1%
2/27 Q4/2019 12/31/2019 EPS 1.080 ZacksConsensus 1.020 ActVsEst 0.060 - Beat -18.7%
8/7 Q2/2019 6/30/2019 EPS 1.440 ZacksConsensus 1.180 ActVsEst 0.260 - Beat -15.1%
4/14 ANI Announces Upcoming Departure of CEO -9.0%
3/2 ANI Pharmaceuticals Announces FDA Approval of Memantine Hydrochloride Extended-Release Capsules -7.8%
3/4 ANI Pharmaceuticals Inc (NASDAQ: ANIP) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. -7.3%
3/7 ANI Pharmaceuticals Inc (NASDAQ: ANIP) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. -6.4%
3/31 Form 4 ANI PHARMACEUTICALS INC For: Mar 28 Filed by: PRZYBYL ARTHUR -6.3%
4/14 ANI Pharmaceuticals Inc (NASDAQ: ANIP) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. -6.0%
1/7 ANI Pharmaceuticals Inc (NASDAQ: ANIP) was downgraded by analysts at BidaskClub from a "strong-buy" rating to a "buy" rating. -5.1%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: